3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Pharmacology

Background:

• T-type calcium channels are crucial drug targets for various neurological conditions.
• Isoxazolyl compounds have shown promise as T-type calcium channel blockers.
• Understanding structure-activity relationships is key to designing effective blockers.

Purpose of the Study:

• To develop and validate quantitative structure-activity relationship (QSAR) models for isoxazolyl T-type calcium channel blockers.
• To identify key physicochemical properties influencing compound activity.
• To guide the design of novel, potent T-type calcium channel blockers.

Main Methods:

• Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) were employed.
• A dataset of 24 isoxazolyl compounds was used to build the models.
• Alignment was performed using four conformations of the most active compound, generated via pharmacophore modeling and random search.

Main Results:

• All CoMFA and CoMSIA models achieved high cross-validated (q²) > 0.5 and conventional (r²) > 0.85 correlation coefficients.
• External validation using a test set of 10 compounds yielded predictive r² values between 0.577 and 0.866.
• The best CoMFA model (Conformer 3 alignment) showed excellent predictive performance (q²=0.756, r²=0.963, pred r²=0.866).

Conclusions:

• CoMFA and CoMSIA models effectively predict the activity of isoxazolyl T-type calcium channel blockers.
• Analysis of contour maps revealed significant contributions from steric, electrostatic, hydrophobic, and hydrogen bonding fields.
• These validated models provide a valuable tool for the rational design of new T-type calcium channel blockers.